Your Recent Quotes: 0 | 0

Pozen Incorporated

Related Information and Financials
Price Glossary Definition
8.75 0.54
6.58%
10/10/08 4:00
Open
7.98
Prev Close
8.21
Volume
469,598
52 Wk. Range
7.40-14.85
Year-to-Date Performance Glossary Definition
DOWN  -31.58%
Latest Dividend
Dividend
N/A
Yield
N/A
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
15.54
 
16.70
 
14.90
POZN
Sect. Av.
S&P 500
Market Cap
258,946,800
Outstanding Shares
29,738,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy POZN Rating Report
Target Price (1Yr)
High
33.00
Revenue
65,640,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
295.40
1.31
0.32
Net Income
-1.89
0.00
EPS
-1.89
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-19.98
-24.33
-17.57
Earnings Per Share($)

12/2005
 
 
 
0.07
12/2006
 
 
 
-0.66
12/2007
 
 
 
0.16

Earnings
EBITDA
2,096,727
Revenue
53,444,345
Outside Analyst Rating History

10/11/08
4
Buy
10/11/08
2
Hold
10/11/08
1
Sell

Jim Cramer Portfolio
Find out now if POZN is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
Latest Headlines
The stock Monday regains some of its sharp Friday losses on the company's positive response to FDA delays. But is the reaction overly optimistic?

11:53AM 05/05/08

Earnings for the first quarter drop off due to generic-drug competition and other hits.

12:34PM 04/23/08

Glaxo may face a tough sell with newly approved Treximet; additional feedback on Elan, and more.

9:00AM 04/19/08

The winner, under the handle 'Nascar,' opens a victory margin of about $3,500.

6:57PM 04/18/08

The Internet giant jumps 20% after it beats estimates.

4:33PM 04/18/08

Isis drops on a Wall Street downgrade.

4:00PM 04/18/08

The contest accelerated on the third day, with large gains and all new leaders.

7:43AM 04/17/08

Frank Curzio reviews a big day for the indices, which got a boost from some strong earnings. Guest Charles Marvin looks at oil data.

5:47PM 04/16/08

Shares climb 5.8% following the company's first-quarter earnings report.

4:36PM 04/16/08

Pozen Pharma climbs on news of regulatory approval for migraine drug Treximet.

3:58PM 04/16/08

Understanding the Market

Our Experts' Take at RealMoney
Here's what our writers like in this market.

3:00PM 10/10/08

I'm working on new downside targets in a revisit to my Dow 8400 scenario.

5:25AM 10/10/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading POZN in his Action Alerts Plus Portfolio?